Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
In receptor-expressing cell assays, the peptide has been reported to activate the GIP receptor, the GLP-1 receptor, and the glucagon receptor and to stimulate downstream cyclic-AMP signaling at each
The peptide concentration becomes too low for practical research use
Designed for convenience and reliability, it helps maintain the stability of reconstituted peptides while reducing contamination risk during handling
Hizentra is billed under Medicare Part B as a parenteral drug provided through durable medical equipment (DME)
Audra Foster, N.D
US$ 20.97
US$ 29.12
US$ 26.47
US$ 26.35
US$ 21.51
US$ 20.49
